<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
70461-024-03
</NDCCode>
<PackageDescription>
10 SYRINGE, GLASS in 1 CARTON (70461-024-03) / .5 mL in 1 SYRINGE, GLASS (70461-024-04)
</PackageDescription>
<NDC11Code>
70461-0024-03
</NDC11Code>
<ProductNDC>
70461-024
</ProductNDC>
<ProductTypeName>
VACCINE
</ProductTypeName>
<ProprietaryName>
Fluad
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/thailand/8/2022 Ivr-237 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated)
</NonProprietaryName>
<DosageFormName>
INJECTION, SUSPENSION
</DosageFormName>
<RouteName>
INTRAMUSCULAR
</RouteName>
<StartMarketingDate>
20240701
</StartMarketingDate>
<EndMarketingDate>
20250731
</EndMarketingDate>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA125510
</ApplicationNumber>
<LabelerName>
Seqirus, Inc.
</LabelerName>
<SubstanceName>
INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED)
</SubstanceName>
<StrengthNumber>
15; 15; 15
</StrengthNumber>
<StrengthUnit>
ug/.5mL; ug/.5mL; ug/.5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-07-08
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20240701
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20250731
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>